SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 29.33+4.6%Oct 31 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JanyBlueEyes who wrote (4884)2/3/1999 12:20:00 PM
From: JanyBlueEyes  Read Replies (3) of 5736
 
CONTEMPORARY PEDIATRICS
December 1998, Vol.15, No. 12

NEW PEDIATRIC PRODUCTS OF '98

No more heel sticks for bilirubin measurements

As parents and pediatricians know, newborn infants frequently become jaundiced, and even a conservative management approach calls for daily monitoring of bilirubin levels in some newborns.

Several years ago, the American Academy of Pediatrics (AAP) issued new guidelines for instituting phototherapy and performing exchange transfusions, resulting in fewer babies' being subjected to phototherapy. For decades, manufacturers have attempted to develop a device that can reliably measure bilirubin levels transcutaneously, which would significantly reduce the number of inconvenient and painful heel sticks. Now the FDA has approved just such a device: The new Colormate TLc-BiliTest is likely to change pediatricians' management of hyperbilirubinemia.

Using a light source and optical filters, the handheld instrument measures the incremental changes of the yellow content of the skin (Figure 3). It is accurate on skin of all races, premature infants, and when used under phototherapy lights. For each set of tests, the operator places over the unit's sensor a $10 TLc-Lensette, which acts as an individual calibration and verification standard, then takes a color measurement from three different sites -- cheek, forehead, and chest of back. The device calculates the bilirubin level in mg/dl. Measurements can be downloaded to either a palmtop of laptop computer and printed for inclusion in the patient's record. The device can be battery powered or rely on an external power source, with a battery backup.

For FDA approval the BiliTest was used on 2,441 newborns of various races and gestational ages. Correlation between BiliTest and serum measurements in infants undergoing phototherapy was 91%; in untreated infants the correlation was 95%. The BiliTest system, which includes the sensor, computer of palmtop, and printer, sells for about $3000, and should be widely used in hospital nurseries, pediatricians' offices, and by home care agencies. END

---------------------------------------------

Contemporary Pediatrics® contributes to the continuing education of pediatricians with articles that are practical, timely, and authoritative. Experts in various pediatric specialties explain to clinicians how best to apply the latest findings and techniques to patient care. The focus is on the prevention, diagnosis, and treatment of clinical problems from birth through adolescence. Also discussed are socioeconomic and practice management issues that affect clinical pediatrics.

Ranked #1 in average issue readership by pediatricians for more than 13 consecutive studies.

Published monthly.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext